Brazil Preclinical Cro Market Size & Outlook, 2026-2033
Related Markets
Brazil preclinical cro market highlights
- The Brazil preclinical cro market generated a revenue of USD 108.1 million in 2025 and is expected to reach USD 168.9 million by 2033.
- The Brazil market is expected to grow at a CAGR of 5.8% from 2026 to 2033.
- In terms of segment, preclinical optimization, efficacy & pk/pd was the largest revenue generating development stage in 2025.
- Early CMC / Phase I–II Supply is the most lucrative development stage segment registering the fastest growth during the forecast period.
Preclinical cro market data book summary
| Market revenue in 2025 | USD 108.1 million |
| Market revenue in 2033 | USD 168.9 million |
| Growth rate | 5.8% (CAGR from 2026 to 2033) |
| Largest segment | Preclinical optimization, efficacy & pk/pd |
| Fastest growing segment | Early CMC / Phase I–II Supply |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Target Discovery, Preclinical Optimization, Efficacy & PK/PD, IND-Enabling Safety (GLP), Bioanalysis & Analytics, Early CMC / Phase I–II Supply |
| Key market players worldwide | Eurofins Scientific SE, Icon PLC, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Intertek Group PLC, Labcorp Holdings Inc, Crown Bioscience, SGA |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.6% of the global preclinical cro market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Latin America, Brazil preclinical cro market is projected to lead the regional market in terms of revenue in 2033.
- Argentina is the fastest growing regional market in Latin America and is projected to reach USD 103.9 million by 2033.
Preclinical optimization, efficacy & pk/pd was the largest segment with a revenue share of 31.54% in 2025. Horizon Databook has segmented the Brazil preclinical cro market based on target discovery, preclinical optimization, efficacy & pk/pd, ind-enabling safety (glp), bioanalysis & analytics, early cmc / phase i–ii supply covering the revenue growth of each sub-segment from 2021 to 2033.
Brazil holds a major share of the preclinical trials outsourcing market in Latin America and is expected to maintain its dominance over the forecast period. Among the Latin American countries, the majority of preclinical trials are conducted in Brazil owing to its cost-effectiveness and diverse population. With a large number of trials conducted in this region, market growth is expected to propel country growth.
The country has witnessed substantial demand from the biotechnology and healthcare industries within the market. Increasing R&D capabilities in Brazil, and government initiatives to collaborate with global companies are likely to attract investments from pharmaceutical and biotech companies. This is expected to boost market growth during the forecast period.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Preclinical CRO Market Scope
Preclinical CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| SGA | View profile | 11-50 | Las Condes, Region Metropolitana, Chile, South America | https://sgasa.cl |
| Crown Bioscience | View profile | 251-500 | Santa Clara, California, United States, North America | http://www.crownbio.com |
| Intertek Group PLC | View profile | 44000 | 33 Cavendish Square, London, United Kingdom, W1G 0PS | https://www.intertek.com |
| Medpace Holdings Inc | View profile | 5800 | 5375 Medpace Way, Cincinnati, OH, United States, 45227 | https://www.medpace.com |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
Brazil Development Stage - Preclinical Cro Market size, 2025 - 2033 (US$M)
Brazil Preclinical CRO Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
